TradingMarkets’ 10 Stocks You Need To Know About Today
AmerisourceBergen
(
ABC |
Quote |
Chart |
News |
PowerRating) lowered Q2 and ’05 guidance by a wide
margin. Trading down in sympathy pre-open: Cardinal Health
(
CAH |
Quote |
Chart |
News |
PowerRating) and
McKesson
(
MCK |
Quote |
Chart |
News |
PowerRating).
The Wall Street Journal reports that 12 AIG executives have
been subpoenaed
Barron’s said Tiffany
(
TIF |
Quote |
Chart |
News |
PowerRating) could be worth as much as $40 to $60
on a takeover basis or at least $40 if management can fix the company’s
problems.
The FDA approved GlaxoSmithKline’s
(
GSK |
Quote |
Chart |
News |
PowerRating) once-per-month Boniva
osteoporosis drug.
Millenium Pharmaceuticals
(
MLNM |
Quote |
Chart |
News |
PowerRating) said the FDA granted expanded
approval for its cancer drug Velcade.
Ligand’s
(
LGND |
Quote |
Chart |
News |
PowerRating) cancer treatment disappointed.
UBS downgraded General Motors
(
GM |
Quote |
Chart |
News |
PowerRating)Â to ‘reduce.’
Morgan Keegan cut estimates on Taser
(
TASR |
Quote |
Chart |
News |
PowerRating) for 2005 and 2006.